<span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span> Editor's PickEditors Pick HomepagePresentationsVenousEditors Pick VenousVenous PresentationsLatest news VenousCX 2018 Podium 1st: The EVRA trial – CX 2018 Manj Gohel, Francine Heatley, Alun Davies, David Epstein, CX 2018 Post Views: 11 Gohel, Manj, Heatley, Francine, Davies, Alun and Epstein, David View all videos
VIVA 2019Editor's PickInterviewsEditors Pick HomepagePeripheralEditors Pick PeripheralPeripheral InterviewsLatest news PeripheralLearning AreasEventsLatest news VenousUncategorized New trial planned to rigorously test catheter-directed thrombolysis for submassive PE treatment
CIRSE 2019Editor's PickInterviewsEditors Pick HomepageIREditors Pick IRIR InterviewsLatest news IRLearning AreasEvents CIRSE 2019: Five-year results from real-world study do not show increased mortality for claudicants treated with DCB
VIVA 2019Editor's PickInterviewsEditors Pick HomepagePeripheralEditors Pick PeripheralPeripheral InterviewsLatest news PeripheralLearning AreasEventsVideo Types More focus needed on best medical therapy and perfusion imaging for CLI procedures
VIVA 2019Editor's PickInterviewsEditors Pick HomepagePeripheralEditors Pick PeripheralPeripheral InterviewsLatest news PeripheralLearning AreasEvents VIVA 2019: PROMISE I trial shows deep vein arterialisation offers hope to no-option CLI patients
VIVA 2019: Open vein hypothesis has “validity” for DVT patients, but other factors at play as well 1 week ago
Add comment